» Articles » PMID: 30702628

Pathomorphological Features of Metastatic Lymph Nodes As Predictors of Postoperative Prognosis in Pancreatic Cancer

Overview
Specialty General Medicine
Date 2019 Feb 1
PMID 30702628
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the pathological features of metastatic lymph nodes (LN) in pancreatic ductal adenocarcinoma (PDAC) and to determine factors with prognostic implications.Metastatic LN status is a proven significant factor for predicting postoperative prognosis in pancreatic cancer patients. However, the effective prognostic criteria regarding metastatic LNs for such disease remain unknown.We retrospectively reviewed 98 patients with R0/1 resection for PDAC. All metastatic LNs were evaluated for the pathomorphological features of metastasis and analyzed in terms of postoperative outcomes. Various morphological patterns of metastasis were assessed in 440 positive LNs and then classified into 4 groups: common type, direct type (continuously invaded by the main tumor), scatter type (multiple tumor clusters among the normal LN tissues), and isolated tumor cell (ITC).The pathological stage was defined as stage IIA in 10% and IIB in 90% patients. Common-type metastasis was noted in 55% positive LNs of 75% node-positive patients; direct type in 36% LNs of 69% patients; scatter type in 5% LNs of 14% patients; and ITCs in 5% LNs of 18% patients. Significant difference was noted only in recurrence-free survival (RFS) but not in overall survival (OS) in the common-type; only in OS but not in RFS for the scatter type; and neither in RFS nor OS for both direct type and ITC. Multivariate analysis revealed that only LN ratio and curability were independent predictive factors of poor.The tumor distribution patterns in metastatic LNs are the postoperative prognostic factors in pancreatic cancer.

Citing Articles

Prognostic patterns in invasion lymph nodes of lung adenocarcinoma reveal distinct tumor microenvironments.

Lao S, Chen Z, Wang W, Zheng Y, Xiong S, He P NPJ Precis Oncol. 2024; 8(1):164.

PMID: 39080406 PMC: 11289302. DOI: 10.1038/s41698-024-00639-1.


Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging.

Shi L, Wang L, Wu C, Wei Y, Zhang Y, Chen J Front Oncol. 2022; 12:927077.

PMID: 35875061 PMC: 9298539. DOI: 10.3389/fonc.2022.927077.


Current Pathology Model of Pancreatic Cancer.

Szymonski K, Milian-Ciesielska K, Lipiec E, Adamek D Cancers (Basel). 2022; 14(9).

PMID: 35565450 PMC: 9105915. DOI: 10.3390/cancers14092321.


Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma.

Speichinger F, Dragomir M, Schallenberg S, Loch F, Degro C, Baukloh A Cancers (Basel). 2022; 14(1).

PMID: 35008365 PMC: 8750597. DOI: 10.3390/cancers14010201.


A radiomics model that predicts lymph node status in pancreatic cancer to guide clinical decision making: A retrospective study.

Liang X, Cai W, Liu X, Jin M, Ruan L, Yan S J Cancer. 2021; 12(20):6050-6057.

PMID: 34539878 PMC: 8425217. DOI: 10.7150/jca.61101.


References
1.
Oettle H, Neuhaus P, Hochhaus A, Hartmann J, Gellert K, Ridwelski K . Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013; 310(14):1473-81. DOI: 10.1001/jama.2013.279201. View

2.
John B, Naik P, Ironside A, Davidson B, Fusai G, Gillmore R . Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival. HPB (Oxford). 2013; 15(9):674-80. PMC: 3948534. DOI: 10.1111/hpb.12019. View

3.
Brown H, Ahrendt S, Komorowski R, Doffek K, Wilson S, Demeure M . Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer. J Surg Res. 2001; 95(2):141-6. DOI: 10.1006/jsre.2000.6026. View

4.
Buc E, Couvelard A, Kwiatkowski F, Dokmak S, Ruszniewski P, Hammel P . Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?. Eur J Surg Oncol. 2014; 40(11):1578-85. DOI: 10.1016/j.ejso.2014.04.012. View

5.
Yi M, Giordano S, Meric-Bernstam F, Mittendorf E, Kuerer H, Hwang R . Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. 2010; 17 Suppl 3:343-51. PMC: 4324560. DOI: 10.1245/s10434-010-1253-3. View